Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Dominari Holdings - 40 Year Stock Price History | DOMH

Historical daily share price chart and data for Dominari Holdings since 1984 adjusted for splits and dividends. The latest closing stock price for Dominari Holdings as of April 26, 2024 is 2.70.
  • The all-time high Dominari Holdings stock closing price was 4016666.34 on February 07, 2000.
  • The Dominari Holdings 52-week high stock price is 3.46, which is 28.1% above the current share price.
  • The Dominari Holdings 52-week low stock price is 1.76, which is 34.8% below the current share price.
  • The average Dominari Holdings stock price for the last 52 weeks is 2.50.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Dominari Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 2.3596 2.5500 3.1400 1.9500 2.7000 4.25%
2023 2.9332 3.4600 4.4500 1.8500 2.5900 -21.04%
2022 6.1757 10.5366 10.5366 3.0700 3.2800 -67.13%
2021 16.6109 14.7084 39.9500 9.7767 9.9790 -32.80%
2020 13.9273 23.8000 54.7400 8.3113 14.8495 -33.83%
2019 43.2289 52.4896 66.4700 17.8500 22.4400 -51.73%
2018 78.0326 99.7050 145.2225 41.1825 46.4929 -54.04%
2017 98.3604 73.6950 283.2200 65.7475 101.1500 34.62%
2016 130.1396 167.4755 221.8075 62.8575 75.1400 -62.59%
2015 772.8686 1482.5699 1551.2074 192.0477 200.8333 -86.45%
2014 3486.1017 11942.7872 11942.7872 1115.4966 1482.5699 -86.60%
2013 11425.0464 9358.0364 29788.6738 5861.6423 11064.3646 18.08%
2012 18903.9254 33495.0987 39532.4529 8909.1471 9370.3911 -70.83%
2011 83371.4185 208657.9917 269058.9892 32122.3487 32122.3487 -83.52%
2010 335134.8915 326714.4869 505171.9798 144550.5692 194930.4922 -37.72%
2009 323643.7760 137247.5395 614991.9754 68637.4973 312986.9875 147.83%
2008 217886.4524 329459.9868 354169.4858 54909.9978 126292.9949 -58.56%
2007 545649.5082 582045.9767 779721.9688 304750.4878 304750.4878 -51.10%
2006 560592.9031 914251.4634 974652.4610 329459.9868 623255.9301 -34.20%
2005 643317.3631 933469.9627 1350785.9460 329459.9868 947197.4621 6.15%
2004 1361611.0598 1737901.4305 2047868.3681 741284.9703 892287.4643 -49.53%
2003 1962757.8715 2020413.3692 2468204.4013 1430130.8928 1768101.9293 -14.13%
2002 1853041.3769 2910229.8836 2910229.8836 1002107.4599 2059124.9176 -20.97%
2001 2246761.0152 1441387.4423 3069468.8772 1424365.3430 2605479.3958 89.80%
2000 1925214.2500 1527321.5889 4016666.3393 1209667.2516 1372749.9451 -9.09%
1999 1613868.0255 2024806.1690 2127762.4149 1106711.0057 1510024.9396 -19.27%
1998 1282966.6513 1269793.6992 2093443.6663 909584.1136 1870509.0752 37.97%
1997 1612076.1472 1784574.9286 3328918.6168 977397.9609 1355727.8458 -20.99%
1996 1850893.8836 1201156.2020 2608224.8957 1201156.2020 1715937.4314 38.89%
1995 1042810.5853 652056.2239 3500512.3600 583418.7267 1235474.9506 80.00%
1994 893409.6329 1063881.2074 1098199.9561 652056.2239 686374.9725 -33.33%
1993 930811.2770 1132518.7047 1475706.1910 617737.4753 1029562.4588 11.11%
1992 1045041.0251 702847.9719 1423541.6931 702847.9719 926606.2129 28.57%
1991 849075.6834 222385.4911 3191643.6223 188066.7425 720693.7212 250.00%
1990 534857.0191 678138.4729 737166.7205 205912.4918 205912.4918 -68.42%
1989 641248.5418 755012.4698 857968.7157 446143.7322 652056.2239 -13.64%
1988 1049670.8039 1148991.7040 1338431.1965 686374.9725 755012.4698 -33.33%
1987 1114048.9782 892287.4643 1441387.4423 720693.7212 1132518.7047 26.92%
1986 891625.5058 583418.7267 1475706.1910 583418.7267 892287.4643 52.94%
1985 406007.1385 377506.2349 823649.9671 274549.9890 583418.7267 54.55%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.002B
Dominari Holdings Inc. primarily focused on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. The Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. Dominari Holdings Inc., formerly known as AIkido Pharma Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.455B 29.78
Chugai Pharmaceutical (CHGCY) Japan $50.600B 22.62
Takeda Pharmaceutical (TAK) Japan $41.238B 6.68
Merck (MKGAF) Germany $20.301B 19.16
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Shionogi (SGIOY) Japan $14.324B 12.39
Sandoz Group AG (SDZNY) Switzerland $14.137B 0.00
Neurocrine Biosciences (NBIX) United States $13.532B 56.19
United Therapeutics (UTHR) United States $11.005B 11.79
Catalent (CTLT) United States $10.120B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.712B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.896B 6.99
Ionis Pharmaceuticals (IONS) United States $6.062B 0.00
Revolution Medicines (RVMD) United States $5.922B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.847B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.932B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.741B 0.00
Summit Therapeutics (SMMT) United States $2.709B 0.00
Indivior (INDV) United States $2.424B 11.49
Corcept Therapeutics (CORT) United States $2.373B 24.00
PTC Therapeutics (PTCT) United States $2.189B 0.00
Dyne Therapeutics (DYN) United States $2.131B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.963B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.905B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.802B 10.67
Evotec AG (EVO) Germany $1.779B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.757B 18.16
Avadel Pharmaceuticals (AVDL) Ireland $1.613B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.89
Ardelyx (ARDX) United States $1.494B 0.00
Soleno Therapeutics (SLNO) United States $1.266B 0.00
Xencor (XNCR) United States $1.232B 0.00
Pacira BioSciences (PCRX) United States $1.225B 12.19
Ironwood Pharmaceuticals (IRWD) United States $1.224B 11.50
Collegium Pharmaceutical (COLL) United States $1.191B 7.33
4D Molecular Therapeutics (FDMT) United States $1.189B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Cassava Sciences (SAVA) United States $0.966B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
Relay Therapeutics (RLAY) United States $0.843B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Sage Therapeutics (SAGE) United States $0.824B 0.00
ARS Pharmaceuticals (SPRY) United States $0.806B 0.00
Enliven Therapeutics (ELVN) United States $0.804B 0.00
Ocular Therapeutix (OCUL) United States $0.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
Siga Technologies (SIGA) United States $0.625B 9.25
Savara (SVRA) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.581B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.525B 0.00
Verve Therapeutics (VERV) United States $0.515B 0.00
Altimmune (ALT) United States $0.515B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Exscientia (EXAI) United Kingdom $0.487B 0.00
ProKidney (PROK) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Larimar Therapeutics (LRMR) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Harrow (HROW) United States $0.372B 0.00
Heron Therapeutics (HRTX) United States $0.368B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.53
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.321B 0.00
Bioventus (BVS) United States $0.315B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Black Diamond Therapeutics (BDTX) United States $0.309B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.282B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.281B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.269B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.231B 0.00
Prelude Therapeutics (PRLD) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
CytoDyn (CYDY) United States $0.142B 0.00
Elite Pharmaceuticals (ELTP) United States $0.142B 13.25
Incannex Healthcare (IXHL) Australia $0.141B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.120B 2.51
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Eliem Therapeutics (ELYM) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
GlycoMimetics (GLYC) United States $0.106B 0.00
Inotiv (NOTV) United States $0.104B 0.00
FibroGen (FGEN) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 6.37
Tempest Therapeutics (TPST) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
JanOne (JAN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
DURECT (DRRX) United States $0.029B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 11.73
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.42